Skip to main content

SR One Capital Management, LP

Position in ENGN — enGene Therapeutics Inc.

CIK 1910264 Redwood City, CA

Position in ENGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,293,607
-$3,798,570 QoQ
Shares Held
747,750
0.0% QoQ
Ownership
1.12%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#15
of 60 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SR One Capital Management, LP holds $1,012,394,333 across 14 Biotechnology names. ENGN ranks #14 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ENGN

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,293,607 747,750
2026-03-31 $5,092,177 747,750
2025-12-31 $6,752,182 747,750
2025-09-30 $5,107,132 747,750
2025-06-30 $2,721,810 747,750
2025-03-31 $3,349,920 747,750
2024-12-31 $4,972,537 747,750
2024-09-30 $4,935,150 747,750
2024-06-30 $4,715,000 500,000